Multiparametric POCUS to Differentiate Fluid Overload From Endothelial Complications After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Series

Bastian Wobbe, MD*

Department of Oncology and Hematology, Klinikum Oldenburg, Oldenburg, Germany

*Corresponding Author: Dr. Bastian Wobbe (email: wobbe.bastian@klinikum-oldenburg.de)


Download article PDF – POCUS Journal 2026;11(2):121-131

DOI: https://doi.org/10.24908/pocusj.v11i02.20532


Abstract

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is frequently complicated by early post-transplant fluid accumulation with weight gain and respiratory compromise. Engraftment syndrome and capillary leak syndrome may resemble fluid overload syndrome, although mechanisms and treatment differ. Conventional parameters such as body weight and clinical criteria do not reliably distinguish intravascular congestion from inflammatory fluid redistribution. We report three allo-HSCT recipients with rapid weight gain and respiratory deterioration. Multiparametric point of care ultrasound (POCUS), integrating inferior vena cava assessment, venous Doppler (applying the VExUS-Score), and lung POCUS, was performed at bedside. Despite similar presentations, POCUS helped to identify distinct patterns. One patient demonstrated systemic venous congestion with interstitial B-lines consistent with fluid overload and improved with decongestive therapy. Two patients showed preserved venous Doppler profiles without congestion; lung POCUS was normal in engraftment syndrome but showed B-lines with pleural effusions in capillary leak syndrome, prompting immunomodulatory therapy. Multiparametric POCUS examination enabled pathophysiology-based differentiation and guided management.

Introduction

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a potentially curative therapy for various hematologic disorders, but is associated with substantial early post-transplant morbidity and mortality [1]. During the conditioning phase and the period of neutrophil recovery, patients frequently develop acute complications characterized by systemic inflammation, endothelial dysfunction, and fluid accumulation. Engraftment syndrome and capillary leak syndrome represent inflammatory endothelial disorders that may present with dyspnea, hypoxemia, edema, and rapid weight gain [2]. In parallel, fluid overload syndrome may develop due to excessive fluid administration, inflammation, capillary leak, renal dysfunction, or impaired mobilization of infused volumes. These entities often manifest with overlapping clinical features, particularly during the vulnerable early post-transplant period [2]. Endothelial injury represents a central mechanism in several early complications after allo-HSCT. Conditioning toxicity, inflammatory immune reconstitution, calcineurin inhibitor exposure, and infectious triggers may promote cytokine-mediated endothelial activation and disruption of vascular barrier integrity. This process results in increased vascular permeability and fluid extravasation into the interstitial compartment [3,4].

Distinguishing between inflammatory endothelial syndromes and intravascular volume overload can be challenging. Conventional diagnostic parameters such as body weight changes, cumulative fluid balance, serum biomarkers, and radiographic findings do not reliably distinguish intravascular congestion from extravascular fluid redistribution [5–8]. Weight gain may reflect third spacing rather than hypervolemia, and pulmonary imaging may demonstrate interstitial infiltrates in both inflammatory and congestion-related states [9]. However, the therapeutic implications differ substantially. While inflammatory syndromes are primarily managed with immunomodulatory therapy and supportive care, fluid overload requires active decongestion through minimizing maintenance fluid administration, diuretics, or renal replacement therapy. Misclassification may therefore result in either insufficient decongestion or harmful over-diuresis in patients.

Point of care ultrasound (POCUS) offers a bedside, non-invasive method for dynamic hemodynamic assessment. In particular, venous Doppler-based approaches, such as the Venous Excess Ultrasound (VExUS) score, allow systemic venous congestion to be estimated by integrating the inferior vena cava (IVC) assessment with hepatic, portal, and intrarenal venous flow patterns [10]. When combined with lung POCUS, this multiparametric approach may provide insight into the distribution of fluid between the intravascular and interstitial compartments [11]. Comprehensive hemodynamic POCUS integrating parameters from cardiac POCUS, IVC assessment, venous Doppler interrogation, and lung POCUS enables bedside evaluation of cardiac function, systemic venous congestion, pulmonary fluid accumulation, and the distribution of fluid between the intravascular and extravascular compartments. Rather than relying on a single parameter, this multiparametric approach provides a physiologically integrated assessment that may be particularly valuable in complex conditions such as allo-HSCT, where several distinct mechanisms of fluid accumulation may coexist. However, its role in differentiating fluid overload syndrome from inflammatory endothelial complications after allo-HSCT has not been systematically investigated. To illustrate this conceptual model of compartment-based fluid accumulation, Figure 1 summarizes the proposed pathophysiological framework.

Figure 1. Conceptual compartment-based framework of fluid accumulation following allogeneic hematopoietic stem cell transplantation. Proposed conceptual framework illustrating the compartment-based distribution of fluid accumulation following allogeneic hematopoietic stem cell transplantation. Fluid accumulation is categorized according to its predominant regional distribution (pulmonary versus systemic) and compartmental distribution (intravascular versus extravascular). The framework highlights the heterogeneous nature of post-transplant fluid accumulation and provides the conceptual basis for a physiology-oriented multiparametric POCUS assessment. Created in BioRender. Allo-HSCT, allogeneic hematopoietic stem cell transplantation; POCUS, point of care ultrasound.

This case series of three allo-HSCT recipients illustrates the application of a comprehensive multiparametric POCUS approach, including lung POCUS and the VExUS framework, in this clinical setting. To our knowledge, this represents the first report applying this integrated POCUS approach to the allo-HSCT population. Integrating cardiac POCUS, venous Doppler assessment, and lung POCUS demonstrated how clinically similar presentations of post-transplant fluid accumulation may reflect fundamentally different hemodynamic and pathophysiological mechanisms with direct therapeutic implications.

Methods

This case series was conducted at a tertiary care university hospital and includes three consecutive adult patients who underwent allogeneic hematopoietic stem cell transplantation and developed clinically significant fluid accumulation with diagnostic uncertainty regarding the underlying pathophysiology. Clinical data, laboratory findings, imaging studies, and POCUS examinations were reviewed retrospectively. The case series was prepared in accordance with the CARE guidelines [12]. Written informed consent for publication of clinical data and images was obtained from all patients.

Multiparametric POCUS was performed as part of routine clinical care to support bedside hemodynamic assessment. The examination protocol included IVC assessment, hepatic vein, portal vein, and intrarenal (interlobar) venous Doppler interrogation, lung POCUS, as well as cardiac POCUS if clinically indicated. Renal venous Doppler assessment was performed in the intraparenchymal (interlobar) veins of the right kidney using a mid-axillary acoustic window. Venous congestion was interpreted according to the published VExUS grading system by integrating IVC diameter with hepatic, portal, and intrarenal venous Doppler findings [10].

All POCUS examinations were performed by a board-certified internist with several years of clinical experience in emergency and intensive care medicine and dedicated expertise in POCUS. POCUS examinations were performed using a Siemens ACUSON Juniper ultrasound system (Siemens Healthineers, Erlangen, Germany) equipped with a 5C1 convex transducer for abdominal and lung POCUS and a 5P1 phased-array transducer for cardiac POCUS. Standard abdominal and cardiac imaging presets were used throughout the studies.

Patients were examined in the supine position whenever feasible. In Case 3, the examination was performed in a 45° semi-recumbent position because severe dyspnea and large pleural effusions precluded a fully supine examination.

A comparative overview of the three cases is provided in Table 1, while representative imaging findings are presented in Figure 2.

Table 1. Comparative summary of the three cases, providing a comparative overview of clinical presentation, multiparametric POCUS findings, presumed underlying pathophysiological mechanism, POCUS-guided management, and clinical outcome.
CharacteristicCase 1Case 2Case 3
Underlying diseaseAMLALLSevere aplastic anemia
Clinical presentationWeight gain, leg edema, dyspnea, hypoxemia, rash, feverWeight gain, dyspnea, hypoxemia, rashWeight gain, generalized edema, dyspnea, hypoxemia
Timing after allo-HSCTPeri-engraftment (d+7 to 14)Peri-engraftment (d+10 to +20)Conditioning phase and stem cell infusion (d-6 to 0)
Maximum weight gain (absolute in kg and relative in %)+8.0 kg (10 %)+9.9 kg (11.7 %)+5.1 kg (7.8%)
Peak oxygen requirement4 L/min nasal cannula4 L/min nasal cannulaInvasive mechanical ventilation
CT findingsNo relevant pulmonary abnormalitiesInterlobular septal thickening, small bilateral pleural effusionsPulmonary edema, bilateral pleural effusions
Cardiac POCUSNot performed; normal baseline echocardiographyNot performed; normal baseline echocardiographyPreserved biventricular function; no significant valvular disease
Lung ultrasoundNo relevant pulmonary congestionBilateral B-linesDiffuse bilateral B-lines and pleural effusions
IVCSmall/collapsibleDilated, reduced respiratory variationSmall, collapsible
VExUSGrade 0Grade 3Grade 0
Systemic venous congestionNoYesNo
Presumed mechanismEngraftment syndromeFluid overload syndromeCapillary leak syndrome
POCUS-guided managementDiuretics discontinued, immunosuppressive treatment initiatedDiuretics intensified, maintenance fluids reduced, corticosteroids taperedCorticosteroids, albumin, CRRT, ventilatory support
Clinical outcomeClinical recoveryClinical recoveryClinical recovery
AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; allo-HSCT, allogeneic hematopoietic stem cell transplantation; CRRT, continuous renal replacement therapy; IVC, inferior vena cava; POCUS, point of care ultrasound; VExUS, Venous Excess Ultrasound.
Figure 2. Multiparametric POCUS patterns in post-transplant fluid disorders. Multiparametric POCUS findings in three patients after allogeneic hematopoietic stem cell transplantation. Created in BioRender. Case 1: Engraftment syndrome: preserved IVC cava dynamics, normal hepatic and portal venous Doppler profiles, and mildly abnormal intrarenal venous Doppler flow, resulting in VExUS grade 0; lung POCUS without pathologic findings. Case 2: Fluid overload syndrome: dilated IVC with reduced respiratory variation, abnormal hepatic and portal venous Doppler waveforms, and elevated VExUS grade consistent with systemic venous congestion; lung POCUS demonstrates bilateral B-lines and pleural effusions. Case 3: Capillary leak syndrome: preserved venous Doppler patterns without evidence of systemic congestion (VExUS grade 0) despite diffuse bilateral B-lines and pleural effusions on lung POCUS. IVC, inferior vena cava; VExUS, Venous Excess Ultrasound score; CT, computed tomography; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia.

Case 1: Engraftment Syndrome

A 65-year-old woman with refractory secondary acute myeloid leukemia underwent allogeneic hematopoietic stem cell transplantation after achieving complete remission following salvage chemotherapy. Conditioning consisted of treosulfan, fludarabine, and anti-thymocyte globulin, followed by infusion of a matched unrelated donor peripheral blood stem cell graft. Graft-versus-host disease prophylaxis included cyclosporine and methotrexate. The patient had no history of cardiac, renal, or hepatic disease. Baseline transthoracic echocardiography demonstrated preserved biventricular function without relevant valvular abnormalities.

During conditioning (day –6 to day -1), the patient gained 4 kg in weight (approximately 5% of baseline body weight) and developed bilateral lower-extremity edema. In response to the progressive weight gain, maintenance intravenous fluids were reduced, and intravenous furosemide was initiated to achieve decongestion. Despite escalation of diuretic therapy, body weight further increased to 8 kg above baseline (approximately 10% of baseline body weight at day +11). Simultaneously, serum creatinine rose from 0.69 to 1.34 mg/dL, consistent with KDIGO stage 1 acute kidney injury. Urinary analysis demonstrated a reduced fractional excretion of sodium, suggestive of a prerenal etiology.

Around neutrophil recovery on day +11, the patient developed fever, an erythematous rash, worsening dyspnea, and hypoxemia requiring 4 L/min of oxygen via nasal cannula. The temporal association with engraftment and multisystem involvement was compatible with engraftment syndrome. However, persistent weight gain with peripheral edema and respiratory deterioration despite intensified diuresis raised concern for concomitant fluid overload syndrome, resulting in diagnostic uncertainty. Hemodynamic status remained stable, without elevated jugular venous pressure or pulmonary crackles on auscultation. ProBNP increased to 4,558 pg/mL. A non-contrast chest CT performed on day +7 demonstrated no relevant pulmonary abnormalities. To further characterize the underlying mechanism of respiratory deterioration and fluid accumulation, a comprehensive POCUS examination was performed at day +11. The IVC was less than 2 cm in diameter with preserved respiratory variation. Hepatic, portal, and intrarenal venous Doppler waveforms were normal, corresponding to VExUS grade 0 and indicating the absence of systemic venous congestion. Lung POCUS demonstrated A-lines without significant pleural effusion.

In the absence of POCUS evidence of intravascular congestion, diuretic therapy was discontinued, and intravenous methylprednisolone was initiated for suspected engraftment syndrome. Within 72 hours, dyspnea and rash improved, oxygen requirements decreased, and body weight progressively declined without further diuretic treatment. Renal function returned to baseline. The patient was later discharged in complete remission.

Case 2: Fluid Overload Syndrome

A 55-year-old man with acute lymphoblastic leukemia underwent allogeneic hematopoietic stem cell transplantation from a matched unrelated donor following myeloablative conditioning with total body irradiation, cyclophosphamide, and anti-thymocyte globulin. Graft-versus-host disease prophylaxis consisted of cyclosporine and methotrexate. The patient had no history of cardiac, renal, or hepatic disease. Baseline echocardiography demonstrated preserved left ventricular systolic function, and renal function was normal before conditioning.

Beginning on day +10, the patient developed progressive weight gain and dyspnea without clinically apparent peripheral edema. By the time of neutrophil engraftment on day +13, body weight had increased by 5.9 kg (baseline weight 84.9 kg), accompanied by hypoxemia requiring supplemental oxygen via nasal cannula. A generalized erythematous rash was present, fulfilling the clinical criteria for suspected engraftment syndrome according to Spitzer et al. [13]. Corticosteroid therapy was initiated, and maintenance intravenous fluid administration was reduced.

Despite appropriate treatment for engraftment syndrome, the patient’s respiratory status continued to deteriorate. Oxygen requirements gradually increased to a maximum of 4 L/min via nasal cannula, while body weight further increased to 9.9 kg above baseline by day +20 (11.7 % of baseline body weight). The lack of clinical response to corticosteroid therapy together with persistent weight gain raised concern for an alternative underlying mechanism.

On day +19, chest computed tomography demonstrated interlobular septal thickening and small bilateral pleural effusions, findings compatible with either inflammatory pulmonary involvement or hydrostatic pulmonary congestion.

As diagnostic uncertainty persisted, a comprehensive multiparametric POCUS examination was performed on the same day. The IVC was dilated (>2 cm) with reduced respiratory variation. Hepatic vein Doppler demonstrated systolic blunting, portal vein Doppler showed marked pulsatility (>50%), and intrarenal venous Doppler revealed abnormal venous flow consistent with VExUS grade 3, indicating clinically significant systemic venous congestion. Lung POCUS demonstrated diffuse bilateral B-lines consistent with pulmonary interstitial edema.

Based on these findings, the working diagnosis was revised from engraftment syndrome to fluid overload syndrome. Corticosteroids were rapidly tapered, maintenance intravenous fluids were further minimized, and intravenous loop diuretic therapy was initiated. Body weight progressively returned to baseline by day +25, accompanied by resolution of hypoxemia, discontinuation of supplemental oxygen, and normalization of follow-up POCUS findings, including regression of B-lines, normalization of venous Doppler waveforms, and restoration of normal IVC dynamics. The patient was later discharged in molecular remission.

Case 3: Capillary Leak Syndrome

A 19-year-old woman with severe aplastic anemia underwent allogeneic bone marrow transplantation from a haploidentical related donor following myeloablative conditioning with cyclophosphamide and anti-thymocyte globulin. The patient had no history of cardiac, renal, or hepatic disease. Baseline echocardiography demonstrated preserved left ventricular systolic function, and renal function was normal before conditioning.

At baseline, the patient weighed 64.3 kg. During conditioning (day –6 to day of transplantation), body weight progressively increased to 69.4 kg (+5.1 kg; +7.8%) over six days despite reduction of maintenance intravenous fluid administration and escalation of diuretic therapy, including continuous intravenous furosemide combined with xipamide. Generalized edema developed together with progressive dyspnea. Laboratory evaluation demonstrated progressive hypoalbuminemia (34.2 g/L on day –4, 29.0 g/L on day –1 despite initiation of albumin substitution, reaching a nadir of 24.6 g/L on day +4), accompanied by elevated inflammatory markers (CRP and ferritin). ProBNP increased from 3,349 pg/mL on day –4 to 58,930 pg/mL on the day of transplantation and subsequently exceeded the upper reporting limit of the local laboratory (>70,000 pg/mL). Repeated echocardiography on the day of transplantation demonstrated preserved biventricular systolic function without relevant structural heart disease or elevated filling pressures.

On the morning of transplantation, supplemental oxygen was at 2 L/min via nasal cannula because of progressive hypoxemia. During infusion of approximately 1,100 mL of bone marrow product, respiratory status rapidly deteriorated despite repeated intravenous furosemide boluses and administration of an additional intravenous prednisolone. Oxygen supplementation was progressively escalated to 8 L/min via face mask. As no clinical improvement was observed, stem cell infusion was temporarily interrupted, and the patient was transferred to the intensive care unit. At this stage of acute clinical deterioration, a comprehensive multiparametric POCUS examination was performed. The IVC was narrow with complete inspiratory collapse. Hepatic, portal, and intrarenal venous Doppler waveforms were normal, corresponding to VExUS grade 0, indicating the absence of clinically significant systemic venous congestion. In contrast, lung POCUS demonstrated diffuse bilateral B-lines and pleural effusions consistent with marked pulmonary interstitial and alveolar fluid accumulation. Initial chest radiography demonstrated pulmonary edema with bilateral effusions. Following escalation to high-flow nasal oxygen and clinical stabilization, stem cell infusion was resumed and completed without further interruption. A chest CT performed on day +9 confirmed diffuse pulmonary edema with bilateral effusions and adjacent compressive atelectasis.

Given the temporal relationship to stem cell infusion, transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI), and capillary leak syndrome were considered as the principal differential diagnoses. Although the infusion volume may have contributed to the rapid respiratory deterioration, the absence of cardiac dysfunction and the lack of sonographic evidence of systemic intravascular congestion argued against clinically significant TACO. Likewise, TRALI was considered less likely because hypoxemia had already developed before stem cell infusion and was not accompanied by fever or hypotension.

Based on the combination of generalized edema, progressive hypoalbuminemia, severe pulmonary fluid accumulation in the absence of systemic venous congestion, and preserved cardiac function, capillary leak syndrome was considered the most likely diagnosis. The patient received systemic corticosteroids, albumin substitution, transient vasopressor support with low-dose norepinephrine, and continuous renal replacement therapy to achieve controlled negative fluid balance. Respiratory support escalated from high-flow nasal oxygen to non-invasive ventilation and finally invasive mechanical ventilation from day +3 to day +7. Continuous renal replacement therapy was required from day +3 until day +26 after transplantation. Follow-up POCUS examinations consistently demonstrated the absence of systemic venous congestion while lung POCUS findings gradually regressed in parallel with clinical recovery. The patient was discharged in stable post-transplant condition.

Comparative synthesis

All three patients presented during the early transplant period with rapid weight gain, respiratory compromise, and clinical features suggestive of endothelial dysfunction. Conventional parameters, including absolute body weight changes and imaging findings, were insufficient to reliably distinguish between inflammatory fluid redistribution and intravascular volume overload. In each case, diagnostic uncertainty directly influenced therapeutic decision-making.

Despite similar clinical presentations, POCUS enabled the identification of distinct phenotypes. In Case 2, sonographic findings demonstrated clear systemic venous congestion, including a dilated IVC with reduced respiratory variation, abnormal hepatic and portal venous Doppler waveforms, and a high VExUS grade, consistent with intravascular volume overload. In contrast, Cases 1 and 3 showed preserved IVC dynamics and normal hepatic, portal, and intrarenal venous Doppler profiles corresponding to VExUS grade 0, indicating the absence of systemic venous congestion. Nevertheless, lung POCUS demonstrated interstitial B-lines in Cases 2 and 3 as well as pleural effusion in Case 3.

Lung POCUS findings alone did not permit differentiation between fluid overload syndrome and inflammatory capillary leak. The integration of venous Doppler assessment with lung POCUS was required to distinguish intravascular congestion from extravascular fluid accumulation. This multiparametric approach enabled pathophysiology-based classification into (1) fluid overload syndrome with systemic venous congestion, (2) engraftment syndrome without venous congestion, and (3) severe capillary leak syndrome characterized by distributive fluid shifts despite preserved venous hemodynamics (Figure 2).

Discussion

This case series illustrates how multiparametric POCUS can help differentiate fluid overload syndrome from inflammatory endothelial complications after allogeneic stem cell transplantation despite overlapping clinical presentations. All three patients developed rapid weight gain, respiratory compromise, and systemic symptoms during the early transplant period. However, venous Doppler–based ultrasound assessment revealed distinct sonographic profiles that directly influenced management decisions. The integration of IVC assessment, hepatic, portal, and intrarenal venous Doppler, together with lung POCUS, enabled classification into intravascular congestion versus non-congestive inflammatory fluid redistribution. This bedside differentiation addressed a clinically relevant diagnostic gap in the setting of hematopoietic stem cell transplantation, where early post-transplant fluid accumulation frequently presents with overlapping clinical features but requires fundamentally different therapeutic strategies.

Fluid accumulation after stem cell transplantation represents a heterogeneous group of pathophysiological processes, reflecting complex interactions between hydrostatic pressure, oncotic pressure, and endothelial permeability that regulate fluid distribution between the intravascular and interstitial compartments [14, 15]. In fluid overload syndrome, intravascular volume expansion leads to elevated central venous pressure and the retrograde transmission of venous congestion to the splanchnic and renal circulations. These changes are reflected by abnormal venous Doppler waveforms and increased portal vein pulsatility [10]. The VExUS framework was developed to identify clinically relevant venous congestion by integrating IVC size with Doppler patterns from abdominal veins [16]. Whereas VExUS primarily reflects systemic venous congestion and elevated right-sided filling pressures, lung POCUS evaluates pulmonary fluid accumulation. Pulmonary B-lines may arise from hydrostatic pulmonary edema due to elevated left-sided filling pressures or from increased alveolo-capillary permeability in inflammatory conditions such as capillary leak syndrome. Consequently, neither modality alone sufficiently characterizes the underlying hemodynamic state. Their combined interpretation provides complementary information regarding fluid distribution across the systemic and pulmonary, intravascular and extravascular compartments. Based on these observations, we propose a multiparametric POCUS-based diagnostic framework for bedside assessment (Figure 3).

Figure 3. Proposed multiparametric POCUS-based diagnostic algorithm for post-transplant fluid accumulation. Proposed diagnostic framework for the bedside evaluation of patients with suspected fluid accumulation following allogeneic hematopoietic stem cell transplantation. Multiparametric POCUS, integrating cardiac POCUS, lung POCUS, IVC assessment, and the VExUS grading system, facilitates differentiation between systemic venous congestion consistent with fluid overload syndrome and inflammatory endothelial complications, including engraftment syndrome and capillary leak syndrome. Alternative causes of respiratory deterioration should be considered according to the clinical presentation. POCUS findings should always be interpreted in conjunction with the clinical context, laboratory findings, timing after transplantation, and conventional imaging. Created in BioRender. POCUS, point of care ultrasound; IVC, inferior vena cava; VExUS, Venous Excess Ultrasound; DAH, diffuse alveolar hemorrhage; IPS, idiopathic pneumonia syndrome; TACO, transfusion-associated circulatory overload; TRALI, transfusion-related acute lung injury.

Although VExUS has been investigated primarily in patients with acute decompensated heart failure and patients following cardiac surgery, evidence in hematopoietic stem cell transplantation is currently lacking [17]. Therefore, VExUS should not be interpreted as a comprehensive assessment of overall “volume status” but rather as a tool for identifying or excluding clinically significant systemic venous congestion. In the present cases, VExUS was interpreted in conjunction with lung POCUS and the overall clinical context, reflecting the complementary role of multiparametric POCUS rather than reliance on a single ultrasound parameter.

Engraftment syndrome and capillary leak syndrome are characterized primarily by endothelial activation, increased vascular permeability, and extravasation of fluid into the interstitial compartment [2,13,18]. In these inflammatory phenotypes, intravascular congestion may be absent despite substantial weight gain and pulmonary interstitial edema. Conventional parameters do not reliably distinguish between these mechanisms because they do not differentiate intravascular from extravascular fluid distribution [5-8].

Diagnostic criteria for engraftment syndrome, capillary leak syndrome, and fluid overload syndrome frequently overlap in clinical practice [2]. Moreover, imaging findings such as interstitial infiltrates and pleural effusions are non-specific [9]. Engraftment syndrome is most commonly defined by the criteria proposed by Spitzer or Maiolino, which include non-infectious fever, skin rash, pulmonary infiltrates with hypoxemia, and weight gain occurring around the time of neutrophil recovery [13,19]. Capillary leak syndrome is characterized by increased vascular permeability leading to generalized edema, hypotension, and pulmonary edema due to fluid extravasation into the interstitial compartment. Fluid overload syndrome, in contrast, is generally characterized by significant weight gain, a positive cumulative fluid balance, and clinical signs of congestion, such as peripheral edema, pulmonary edema, or pleural effusions. Despite these conceptual differences, the clinical manifestations of these syndromes frequently overlap in the early post-transplant period, making differentiation based solely on clinical criteria difficult [2]. In this context, lung POCUS alone does not permit mechanistic classification, as B-lines may occur in both venous congestion and inflammatory pulmonary edema [20]. The addition of venous Doppler assessment provides complementary information by identifying or excluding systemic venous congestion. In the present cases, this multiparametric approach allowed differentiation between congestion-driven respiratory compromise and distributive fluid shifts despite similar clinical presentation [11].

The therapeutic implications of this distinction are clinically significant. Real-world management patterns further highlight the diagnostic uncertainty in this setting. In cohorts of patients with engraftment syndrome, treatment has been heterogeneous: most received corticosteroids, while others were managed conservatively or treated with diuretics alone or in combination with corticosteroids [21]. The use of diuretics in a primarily inflammatory syndrome likely reflects the difficulty in distinguishing engraftment syndrome from fluid overload syndrome in the presence of weight gain and respiratory compromise. This overlap underscores that current clinical assessment does not reliably differentiate between intravascular congestion and inflammatory fluid redistribution.

Management of fluid overload syndrome requires active decongestion through reduced maintenance fluids, diuretic therapy, or renal replacement therapy, whereas inflammatory endothelial syndromes primarily require immunomodulatory treatment and supportive care [2,22]. Misclassification may result in inappropriate escalation of corticosteroids or, conversely, harmful overdiuresis in patients without true intravascular volume expansion. POCUS offers a rapid, repeatable, and non-invasive method to guide these decisions. Incorporating multiparametric POCUS into routine peri-transplant assessment may therefore enhance individualized fluid stewardship [23].

The differential diagnosis of respiratory deterioration and fluid accumulation after allo-HSCT is broad and includes hydrostatic fluid overload, engraftment syndrome, capillary leak syndrome, infection, idiopathic pneumonia syndrome, diffuse alveolar hemorrhage, TACO, TRALI, and pulmonary thromboembolism [2]. As these conditions frequently present with overlapping clinical features, laboratory findings, and conventional imaging, establishing the predominant underlying pathophysiology may be challenging.

This study has several limitations. It represents a small retrospective case series from a single center. POCUS findings were interpreted in conjunction with clinical judgment. The observations were, therefore, hypothesis-generating. Larger, prospective studies are needed to validate standardized POCUS algorithms in the hematopoietic stem cell transplantation setting and to determine whether POCUS-guided fluid management improves clinical outcomes. In addition, POCUS assessment is operator-dependent and may vary with the examiner’s experience. Several physiological and technical factors may also influence VExUS interpretation, including positive-pressure ventilation, marked hypoalbuminemia, and limited acoustic windows [10,16]. An additional limitation is that lung POCUS findings were evaluated primarily for the presence of B-lines and pleural effusions. Detailed lung POCUS characteristics, including the distribution and density of B-lines, pleural line morphology, and subpleural consolidations, were not systematically documented due to the retrospective nature of this case series. Future prospective studies should investigate whether advanced lung POCUS features provide additional value in differentiating hydrostatic pulmonary edema from inflammatory endothelial complications after allo-HSCT.

Beyond the individual cases presented, this series highlights the potential value of multiparametric POCUS as a physiological phenotyping tool in allo-HSCT recipients. Rather than identifying fluid accumulation alone, the combined interpretation of cardiac POCUS, VExUS, and lung POCUS may distinguish systemic venous congestion from endothelial permeability-related pulmonary edema, thereby differentiating clinically similar respiratory syndromes with fundamentally different hemodynamic mechanisms. The application of this integrated congestion-focused POCUS framework in the allo-HSCT population has not previously been described and may provide a useful foundation for future prospective studies. The proposed framework is intended as a hypothesis-generating bedside approach rather than a validated diagnostic algorithm and should be prospectively evaluated.

Conclusion

POCUS enabled bedside differentiation between fluid overload syndrome and inflammatory endothelial complications, namely engraftment syndrome and capillary leak syndrome, after allogeneic stem cell transplantation despite overlapping clinical features. The integration of venous Doppler assessment with lung POCUS allowed the identification of distinct fluid distribution phenotypes and guided targeted management strategies. In a clinical setting where weight gain and respiratory deterioration are common but mechanistically heterogeneous, multiparametric ultrasound may support pathophysiology-based decision-making. Prospective studies are warranted to determine whether structured POCUS-guided fluid management improves outcomes in stem cell transplant recipients.

Ethics Statement

Written informed consent was obtained from all patients for publication of this retrospective case series, including the accompanying anonymized clinical information, laboratory data, and images

Disclosure Statement

The author declares that there are no conflicts of interest related to this work.

Funding

No funding to declare.

Artificial Intelligence Statement

During the preparation of this work the author used a large language model (ChatGPT, OpenAI) to edit for clarity and language. After using this tool, the author reviewed and edited the content as needed and takes full responsibility for the content of the published article.

References

1. Penack O, Peczynski C, Mohty M, Yakoub-Agha I, Styczynski J, Montoto S, Duarte RF, Kröger N, Schoemans H, Koenecke C, Peric Z, Basak GW. How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Adv. 2020;4(24):6283–6290. doi: 10.1182/ bloodadvances.2020003418

2. Sureda A, Corbacioglu S, Greco R, Kröger N, Carreras E, editors. The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies. 8th ed. Cham: Springer International Publishing; 2024. doi: 10.1007/978-3-031-44080-9

3. McEwan A, Greenwood M, Ward C, Ritchie D, Szer J, Gardiner E, Colic A, Sipavicius J, Panek-Hudson Y, Kerridge I. Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantation. Intern Med J. 2023;53(12):2162–2174. doi: 10.1111/ imj.16188

4. Vythoulkas D, Tsirigotis P, Griniezaki M, Konstantellos I, Lazana I. Endothelial dysfunction syndromes after allogeneic stem cell transplantation. Cancers 2023;15(3):680. doi: 10.3390/ cancers15030680

5. Koratala A, Ronco C, Kazory A. Diagnosis of fluid overload: from conventional to contemporary concepts. Cardiorenal Med. 2022;12 (4):141–154. doi: 10.1159/000526902

6. Raco J, Peterson B, Muallem S. Assessment of volume status in hospitalized patients with chronic heart failure. Cardiol Res. 2023;14 (1):2–11. doi: 10.14740/cr1434

7. Perren A, Markmann M, Merlani G, Marone C, Merlani P. Fluid balance in critically ill patients. Should we really rely on it? Minerva Anestesiol 2011;77(8):802–811.

8. Gonzalez F, Vincent F. The fluid balance in the critically ill patients: what are we talking about? Minerva Anestesiol. 2011;77(8):766–767. 9. Franquet T, Müller NL, Lee KS, Giménez A, Flint JD. High-resolution CT and pathologic findings of noninfectious pulmonary complications after hematopoietic stem cell transplantation. AJR Am J Roentgenol. 2005;184(2):629–637. doi: 10.2214/ajr.184.2.01840629

10. Assavapokee T, Rola P, Assavapokee N, Koratala A. Decoding VExUS: a practical guide for excelling in point-of-care ultrasound assessment of venous congestion. Ultrasound J. 2024;16(1):48. doi: 10.1186/s13089-024-00396-z

11. de la Espriella R, Cobo M, Santas E, Verbrugge FH, Fudim M, Girerd N, Miñana G, Górriz JL, Bayés-Genís A, Núñez J. Assessment of filling pressures and fluid overload in heart failure: an updated perspective. Rev Esp Cardiol (Engl Ed). 2023;76(1):47–57. doi: 10.1016/j.rec.2022.07.009

12. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, the CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Reports CP 2013;2013:bcr2013201554. doi: 10.1111/head.12246

13. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27(9):893–898. doi: 10.1038/sj.bmt.1703015

14. Milone G, Bellofiore C, Leotta S, Milone GA, Cupri A, Duminuco A, Garibaldi B, Palumbo G. Endothelial dysfunction after hematopoietic stem cell transplantation: a review based on physiopathology. J Clin Med. 2022;11(3):623. doi: 10.3390/jcm11030623

15. Palomo M, Diaz-Ricart M, Carreras E. Endothelial dysfunction in hematopoietic cell transplantation. Clin Hematol Int. 2019;1(1):45–51. doi: 10.2991/chi.d.190317.001

16. Rola P, Miralles-Aguiar F, Argaiz E, Beaubien-Souligny W, Haycock K, Karimov T, Dinh VA, Spiegel R. Clinical applications of the venous excess ultrasound (VExUS) score: conceptual review and case series. Ultrasound J. 2021;13(1):32. doi: 10.1186/s13089-021-00232-8

17. González-Vázquez MD, García Casasola-Sánchez G, Tung-Chen Y. Evidence of the usefulness of VEXUS score in the diagnosis and treatment of the syndrome cardiorenal: a narrative review. Span J Med. 2023;3(2):35–43. doi: http://dx.doi.org/10.24875/SJMED.23000004

18. Saravi B, Goebel U, Hassenzahl LO, Jung C, David S, Feldheiser A, Stopfkuchen-Evans M, Wollborn J. Capillary leak and endothelial permeability in critically ill patients: a current overview. Intensive Care Med Exp. 2023;11(1):96. doi: 10.1186/s40635-023-00582-8

19. Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M. Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria. Bone MarrowTransplant. 2003;31(5):393–397. doi: 10.1038/sj.bmt.1703855.

20. Picano E, Pellikka PA. Ultrasound of extravascular lung water: a new standard for pulmonary congestion. Eur Heart J. 2016;37(27):2097 –2104. doi: 10.1093/eurheartj/ehw164

21. Pramanik R, Kancharla H, Bakhshi S, Sharma A, Gogia A, Malik P, Sahoo RK, Batra A, Thulkar S, Kumar L. Engraftment syndrome: a retrospective analysis of the experience at a tertiary care institute. Clin Hematol Int. 2019;1(2):114–119. doi: 10.2991/chi.d.190504.001

22. Elbahlawan L, Qudeimat A, Morrison R, Schaller A. Fluid overload in children following hematopoietic cell transplant: a comprehensive review. J Clin Med. 2024;13(21):6348. doi: 10.3390/jcm13216348

23. Hawkins WA, Smith SE, Newsome AS, Carr JR, Bland CM, Branan TN. Fluid stewardship during critical illness: a call to action. J Pharm Pract. 2020;33(6):863–873. doi: 10.1177/0897190019853979

Posted in .

Leave a Reply

Your email address will not be published. Required fields are marked *